NCT03475498 A Major Determinant Focused on the ECG or Echocardiogram for PICM and Its Clinical Outcome (PICM Syndrome)
| NCT ID | NCT03475498 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Eulji University Hospital |
| Condition | Pacemaker Complication |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2018-01-30 |
| Primary Completion | 2027-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2018-01-30 with a primary completion date of 2027-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Chronic right ventricular pacing has a deleterious effect on left ventricular (LV) function, namely pacing-induced cardiomyopathy (PICM). Several parametes make difference of effect on the occurrence of PICM and its subsequent clinical outcomes. In particular, recognition of a major determinant focused on the ECG or echocardiographic parameters including strain or genetic factor for occurrence of PICM may lead to better identification of patients at high risk. Investigators prospectively enroll a participant with documented high risk of PICM and clinically follow-up to idenify clinical impact of PICM (PICM syndrome) over a long period of time.
Eligibility Criteria
Inclusion Criteria: mandatory (1 and 2) and optional (3 or 4) 1. Willng to participate in the study and able to sign informed consent 2. Undertaken ECG and echocardiogram including strain before and after device implantation Exclusion Criteria: 1. Less than 18 years of age 2. Being pregnant or plan to become pregnant 3. Advanced heart failure waiting in heart transplantation 4. Have a life expectancy of less than 1 year
Contact & Investigator
KI-Woon Kang, MD PhD
PRINCIPAL INVESTIGATOR
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
Frequently Asked Questions
Who can join the NCT03475498 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Pacemaker Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03475498 currently recruiting?
Yes, NCT03475498 is actively recruiting participants. Contact the research team at kwkang0115@gmail.com for enrollment information.
Where is the NCT03475498 trial being conducted?
This trial is being conducted at Chungju, South Korea, Daejeon, South Korea, Seoul, South Korea.
Who is sponsoring the NCT03475498 clinical trial?
NCT03475498 is sponsored by Eulji University Hospital. The principal investigator is KI-Woon Kang, MD PhD at Chung-Ang University Hosptial, Chung-Ang University College of Medicine. The trial plans to enroll 1,000 participants.